Estimation of natural history parameters of breast cancer based on non-randomized organized screening data: Subsidiary analysis of effects of inter-screening interval, sensitivity, and attendance rate on reduction of advanced cancer

Breast Cancer Research and Treatment

Volumn 122, Issue 2, 2010, Pages 553-566

  Wu, Jenny Chia Yun ^a   Hakama, Matti ^a,b   Anttila, Ahti ^b   Yen, Amy Ming Fang ^c   Malila, Nea ^a,b   Sarkeala, Tytti ^a   Auvinen, Anssi ^a   Chiu, Sherry Yueh Hsia ^a   Chen, Hsiu Hsi ^a  

^a UNIVERSITY OF TAMPERE   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Attendance rate.; Breast cancer service screening; Inter screening interval; Markov model; Natural history; Sensitivity

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER SCREENING; COMPUTER SIMULATION; CONTROLLED STUDY; FEMALE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; BREAST NEOPLASMS; INCIDENCE; MASS SCREENING; MIDDLE AGED; PATIENT COMPLIANCE; PREDICTIVE VALUE; PROBABILITY; PROCEDURES; PROGRAM EVALUATION; REGISTER; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TIME;

ADULT; BREAST NEOPLASMS; COMPUTER SIMULATION; FEMALE; FINLAND; HUMANS; INCIDENCE; MAMMOGRAPHY; MARKOV CHAINS; MASS SCREENING; MIDDLE AGED; MODELS, STATISTICAL; PATIENT COMPLIANCE; PREDICTIVE VALUE OF TESTS; PROGRAM EVALUATION; REGISTRIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 77955654008     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0701-x     Document Type: Article

References (15)

1. Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, Smith RA (1995) Efficacy of breast cancer screening by age. Cancer 75:2507-2517.
2. Chen HH, Duffy SW, Tabar L, Day NE (1997) Markov chain models for progression of breast cancer. Part I: tumour attributes and the preclinical screen-detectable phase. J Epidemiol Biostat 2:9-23.
3. Chen HH, Duffy SW, Tabar L, Day NE (1997) Markov chain models for progression of breast cancer. Part II: prediction of outcomes for different screening regimes. J Epidemiol Biostat 2:25-35.
4. Lai MS, Yen MF, Kuo HS, Koong SL, Chen THH, Duffy SW (1998) Efficacy of breast-cancer screening for female relatives of breast-cancer-index cases: Taiwan multicentre cancer screening (TAMCAS). Int J Cancer 78:21-26.
5. Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, Smith RA (1995) Efficacy of breast cancer screening by age. Cancer 1995:2507-2517.
6. Weedon-Fekjær H, Vatten LJ, Aalen OO, Lindqvist B, Tretli S (2005) Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results. J Med Screen 12:172-178.
7. Sarkeala T, Anttila A, Forsman H, Luostarinen T, Saarenmaa I, Hakama M (2004) Process indicators from ten centres in the Finnish breast cancer screening programme from 1991 to 2000. Eur J Cancer 40:2116-2125. doi:10.1016/j.ejca.2004.06.017. (Pubitemid 39165546)
8. Wu JC, Anttila A, Yen AM, Hakama M, Saarenmaa I, Sarkeala T, Malila N, Auvinen A, Chiu SY, Chen THH (2009) Evaluation of breast cancer service screening programme with a Bayesian approach: mortality analysis in a Finnish region. Breast Cancer Res Treat (in press). doi:10.1007/s10549-009-0604-x.
9. Chen HH, Duffy SW, Tabar L (1996) A markov chain method to estimate the tumour progression rate from preclinical to clinical phase, sensitivity and positive predictive value for mammography in breast cancer screening. The Stat 45:307-317.
10. Chen THH, Kuo HS, Yen MF, Lai MS, Tabar L, Duffy SW (2000) Estimation of sojourn time in chronic disease screening without data on interval cases. Biometrics 56:167-172.
11. Sarkeala T, Hakama M, Saarenmaa I, Hakulinen T, Forsman H, Anttila A (2006) Episode sensitivity in association with process indicators in the Finnish breast cancer screening program. Int J Cancer 118:174-179. doi:10.1002/ijc. 21310. (Pubitemid 41681595)
12. Duffy SW, Day NE, Tabar L, Chen HH, Smith TC (1997) Markov models of breast tumor progression: some age-specific results. J Natl Cancer Inst Monogr 22:93-97.
13. Anttila A, Koskela J, Hakama M (2002) Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen 9:153-158.
14. Duffy SW, Chen HH, Tabar L, Day NE (1995) Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. Statist Med 14:1531-1543.
15. Kay R (1986) A Markov model for analyzing cancer markers and disease states in survival studies. Biometrics 42:855-865.